https://pharminent.com/ptc-therapeutics-acquires-sangamos-fabry-disease-gene-therapy/ 2026-08-13T20:38:49Z Pharminent en PTC Therapeutics Acquires Sangamo's Fabry Disease Gene Therapy 2026-08-13T20:30:29Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-13-2026/ 2026-08-13T19:20:54Z Pharminent en Strategic News Watch • August 13, 2026 2026-08-13T18:34:45Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-august-12-2026/ 2026-08-13T17:42:04Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • August 12, 2026 2026-08-13T17:42:02Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-august-12-2026/ 2026-08-13T17:39:32Z Pharminent en Manufacturing Intelligence • Weekly Digest • August 12, 2026 2026-08-13T17:39:29Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-august-11-2026/ 2026-08-13T17:38:05Z Pharminent en Oncology Intelligence Digest • August 11, 2026 2026-08-13T17:38:03Z Blog https://pharminent.com/eli-lilly-files-six-lawsuits-to-combat-illegal-retatrutide-black-market/ 2026-08-13T17:50:39Z Pharminent en Eli Lilly Files Six Lawsuits to Combat Illegal Retatrutide Black Market 2026-08-12T20:01:12Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-12-2026/ 2026-08-12T19:16:05Z Pharminent en Strategic News Watch • August 12, 2026 2026-08-12T19:16:01Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-august-10-2026/ 2026-08-11T20:38:03Z Pharminent en Rare Disease & Gene Therapy Digest • August 10, 2026 2026-08-11T20:37:59Z Blog https://pharminent.com/trump-executive-order-strips-seven-vaccines-from-childhood-immunization-recommendations/ 2026-08-12T19:55:01Z Pharminent en Trump Executive Order Strips Seven Vaccines From Childhood Immunization Recommendations 2026-08-11T20:04:51Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-august-11-2026/ 2026-08-11T19:23:36Z Pharminent en Strategic News Watch • August 11, 2026 2026-08-11T19:23:32Z Blog https://pharminent.com/chasing-dupixent-a-biotech-aims-to-make-better-antibody-drugs-for-eczema/ 2026-08-11T19:25:15Z Pharminent en Chasing Dupixent, a biotech aims to make better antibody drugs for eczema 2026-08-11T13:40:00Z Blog https://pharminent.com/bms-banks-on-texas-for-2-3bn-multi-modal-manufacturing-facility/ 2026-08-11T19:26:07Z Pharminent en BMS banks on Texas for $2.3bn multi-modal manufacturing facility 2026-08-11T10:25:55Z Blog https://pharminent.com/jazz-pharmaceuticals-to-acquire-actio-biosciences-for-820m-upfront/ 2026-08-11T19:29:46Z Pharminent en Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront 2026-08-11T09:31:06Z Blog